| RNF217 |
Q8TC41
|
ring finger protein 217
|
Enzyme
|
2.0E-05 |
0.839 |
0.115 |
| MDS2 |
Q8NDY4
|
myelodysplastic syndrome 2 translocation associated
|
|
0.38 |
0.861 |
0.115 |
| IGHV3-41 |
|
immunoglobulin heavy variable 3-41 (pseudogene)
|
|
|
0.890 |
0.115 |
| MIR181B1 |
|
microRNA 181b-1
|
|
|
0.890 |
0.115 |
| CLLU1 |
Q5K131
|
chronic lymphocytic leukemia up-regulated 1
|
|
1.7E-03 |
1.000 |
0.115 |
| IGLV3-21 |
P80748
|
immunoglobulin lambda variable 3-21
|
Immune response
|
|
1.000 |
0.115 |
| SPRYD7 |
Q5W111
|
SPRY domain containing 7
|
|
2.1E-04 |
0.931 |
0.115 |
| IGLJ2 |
|
immunoglobulin lambda joining 2
|
|
|
1.000 |
0.115 |
| DUSP5P1 |
|
dual specificity phosphatase 5 pseudogene 1
|
|
|
0.890 |
0.115 |
| DACT3-AS1 |
|
DACT3 antisense RNA 1
|
|
|
0.931 |
0.115 |
| IGHV3-30 |
P01768
|
immunoglobulin heavy variable 3-30
|
|
|
0.931 |
0.115 |
| IGHV3-11 |
P01762
|
immunoglobulin heavy variable 3-11 (gene/pseudogene)
|
|
|
0.931 |
0.115 |
| CLEC17A |
Q6ZS10
|
C-type lectin domain containing 17A
|
|
9.1E-08 |
1.000 |
0.115 |
| MRD4 |
|
Mental retardation, autosomal dominant 4
|
|
|
1.000 |
0.115 |
| FRA16A |
|
fragile site, folic acid type, rare, fra(16)(p13.11)
|
|
|
1.000 |
0.115 |
| IGHV4-38-2 |
P0DP08
|
immunoglobulin heavy variable 4-38-2
|
|
|
1.000 |
0.115 |
| IGHD3-3 |
|
immunoglobulin heavy diversity 3-3
|
|
|
1.000 |
0.115 |
| IGKV2-30 |
P06310
|
immunoglobulin kappa variable 2-30
|
Immune response
|
|
1.000 |
0.115 |
| IGKV1-39 |
P01597
|
immunoglobulin kappa variable 1-39 (gene/pseudogene)
|
Immune response
|
|
1.000 |
0.115 |
| IGKJ2 |
|
immunoglobulin kappa joining 2
|
|
|
1.000 |
0.115 |
| IGKJ1 |
A0A0A0MT89
|
immunoglobulin kappa joining 1
|
|
|
1.000 |
0.115 |
| LAX1 |
Q8IWV1
|
lymphocyte transmembrane adaptor 1
|
Enzyme
|
3.0E-04 |
1.000 |
0.115 |
| TMCC3 |
Q9ULS5
|
transmembrane and coiled-coil domain family 3
|
|
2.7E-05 |
1.000 |
0.115 |
| DOHH |
Q9BU89
|
deoxyhypusine hydroxylase
|
|
1.6E-02 |
0.743 |
0.154 |
| KLHL6 |
Q8WZ60
|
kelch like family member 6
|
|
4.0E-06 |
0.805 |
0.154 |